Development of new drug delivery system for protein drugs using silicone (I)

J Control Release. 2000 May 3;66(1):49-61. doi: 10.1016/s0168-3659(99)00257-6.

Abstract

A novel technique, by which protein drugs effective in small doses can be released over a long period, was developed using silicone and a water-soluble substance. In this study, interferon (IFN) was used as a model of the protein drugs. The IFN-silicone formulation released IFN over long periods of time in vitro and suppressed tumor growth in nude mice for about 100 days after a single administration. This indicates that physiologically active IFN is released over a prolonged period of time from the IFN-silicone formulation in vivo. Silicone formulations are expected to be a practically feasible sustained-release formulation.

MeSH terms

  • Animals
  • Delayed-Action Preparations*
  • Dimethylpolysiloxanes
  • Female
  • Glycine / chemistry
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / pharmacokinetics
  • Interferon-alpha / therapeutic use
  • Kinetics
  • Mice
  • Mice, Nude
  • Microscopy, Confocal
  • Neoplasm Transplantation
  • Osmotic Pressure
  • Particle Size
  • Powders
  • Silicones / chemistry*
  • Solubility
  • Tumor Cells, Cultured

Substances

  • Delayed-Action Preparations
  • Dimethylpolysiloxanes
  • Interferon-alpha
  • Powders
  • Silicones
  • baysilon
  • Glycine